BLK
64
-12
PPG
50
-3
SPG
37
-4
KHC
45
-2
DLTR
56
-2
FTI
64
-2
SLB
42
-6
VFC
33
-3
MUR
44
-5
HD
31
-6
EQR
33
-3
APH
58
-4
IPG
45
-4
MRK
41
-9
FOX
60
-2
SJM
38
-3
MTCH
50
-3
NUE
55
-5
LLY
62
-6
PEG
36
-5
BLK
64
-12
PPG
50
-3
SPG
37
-4
KHC
45
-2
DLTR
56
-2
FTI
64
-2
SLB
42
-6
VFC
33
-3
MUR
44
-5
HD
31
-6
EQR
33
-3
APH
58
-4
IPG
45
-4
MRK
41
-9
FOX
60
-2
SJM
38
-3
MTCH
50
-3
NUE
55
-5
LLY
62
-6
PEG
36
-5
Financhill
Back

Simplify Opportunistic Income ETF Vs. CRISPR Therapeutics AG Sector Stock Comparison

Sell
35

CRDT
Simplify Opportunistic Income ETF

Last Price:
$23.92
Seasonality Move:
0.71%
Sell
36

CRSP
CRISPR Therapeutics AG

Last Price:
$52.73
Seasonality Move:
-15.72%
Sell
35
Simplify Opportunistic Income ETF (CRDT) is a Sell

Is Simplify Opportunistic Income ETF a Buy, Sell or Hold?

  • The current Simplify Opportunistic Income ETF [CRDT] share price is $23.92. The Score for CRDT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CRDT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $52.73. The Score for CRSP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRDT Stock Price Chart

What is Simplify Opportunistic Income ETF's stock price today?

  • The Simplify Opportunistic Income ETF share price today is $23.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRDT is experiencing slight buying pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $52.73
    The current trend is moderately bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

CRDT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 34.68 Sell
Chaikin Money Flow: -1286 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.13 Buy
Relative Strength Index (14 RSI): 59.06 Buy
Chaikin Money Flow: -2567846 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CRDT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.92 Sell
20-day SMA: 24.18 Sell
50-day SMA: 24.46 Sell
200-day SMA: 25.09 Sell
8-day EMA: 23.96 Sell
20-day EMA: 24.12 Sell
50-day EMA: 24.43 Sell
200-day EMA: 24.96 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.4 Sell
20-day SMA: 49.98 Buy
50-day SMA: 42.8 Buy
200-day SMA: 43.49 Buy
8-day EMA: 54.56 Sell
20-day EMA: 50.75 Buy
50-day EMA: 43.78 Buy
200-day EMA: 23.06 Buy

Simplify Opportunistic Income ETF Earnings Growth & CRDT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.23 per share, and an increase next year of $0.86 per share.

Simplify Opportunistic Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):